US · Healthcare

MJardin Group Inc (MJARF)

Drug Manufacturers - Specialty & Generic

MJardin Group Inc (MJARF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MJARF

P/E ratio

18.00

MJardin Group Inc (MJARF) — FAQ

What is MJARF's P/E ratio?

The price-to-earnings (P/E) ratio for MJardin Group Inc (MJARF) is 18.00 (data as of 2026-03-24).

Does MJardin Group Inc pay a dividend?

Dividend yield is not available in the current snapshot for MJardin Group Inc (MJARF). Check the MyAverix Finance app for the latest dividend data.

What sector is MJardin Group Inc in?

MJardin Group Inc (MJARF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is MJARF listed on?

MJARF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)